Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Virus Diseases 1Sexually Transmitted Diseases 1Papillomavirus Infections 1Keratosis, Actinic 1Condylomata Acuminata 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11Vaccines, Synthetic 7Papillomavirus Vaccines 6Vaccines 3Imiquimod 3Gels 3green tea extract polyphenone E 2Trichloroacetic Acid 2Duration of Therapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1human papillomavirus vaccine, L1 type 16, 18 1berdazimer sodium 1Viusid 1VP-102 1Therapies, Investigational 1Tea 1Surgical Procedures, Operative 1Omiganan 1Ointments 1Medical Records 1Interleukin-4 1Human Papillomavirus Recombinant Vaccine nonavalent 1Hepatitis B Vaccines 1GS-9191 1Ethanol 1Cyclophosphamide 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Condylomata Acuminata × Therapies, Investigational × Clear all
NCT02482428 2021-01-05

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Novartis

Phase 2 Completed
88 enrolled 10 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡